CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of 15 million
Provides immediate new financing to support the Company’s next strategic milestones Strengthens…
Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program
November 28, 2025 20:13 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
Enovix Announces Completion of Warrant Dividend Program
September 05, 2025 18:08 ET | Source: Enovix Corporation Warrants Expired and…
Satisfaction of Additional Price Condition and Confirmation of Warrant Expiration Date
August 28, 2025 17:55 ET | Source: Enovix Corporation Alternate Price Condition…
Enovix Shareholder Second Reminder: Early Warrant Expiration Price Condition
Enovix Warrants: 14 of 14 Trading Days Above $10.50 August 08, 2025…
Enovix Shareholder Reminder: Early Warrant Expiration Price Condition
Enovix Warrants: 9 of 9 Trading Days Above $10.50 August 01, 2025…
Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless
NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics…
PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results
June 16, 2025 19:20 ET | Source: PolyPid Ltd. The Company Anticipates…
